• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫嘌呤类药物在人肝细胞体外模型中的药代动力学和药效学:来自创新质谱分析的见解

Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay.

作者信息

Pelin Marco, Genova Elena, Fusco Laura, Marisat Monzer, Hofmann Ute, Favretto Diego, Lucafò Marianna, Taddio Andrea, Martelossi Stefano, Ventura Alessandro, Stocco Gabriele, Schwab Matthias, Decorti Giuliana

机构信息

Department of Life Sciences, University of Trieste, I-34127 Trieste, Italy.

PhD School in Reproduction and Developmental Sciences, University of Trieste, I-34127 Trieste, Italy.

出版信息

Chem Biol Interact. 2017 Sep 25;275:189-195. doi: 10.1016/j.cbi.2017.08.009. Epub 2017 Aug 12.

DOI:10.1016/j.cbi.2017.08.009
PMID:28811125
Abstract

AIM

To apply an innovative LC-MS/MS method to quantify thiopurine metabolites in human hepatocytes and to associate them to cytotoxicity.

METHODS

Immortalized human hepatocytes (IHH cells) were treated for 48 and 96 h, with 1.4 × 10 M azathioprine and 1.1 × 10 M mercaptopurine, concentrations corresponding to the IC values calculated after 96 h exposure in previous cytotoxicity analysis. After treatments, cells were collected for LC-MS/MS analysis to quantify 11 thiopurine metabolites with different level of phosphorylation and viable cells were counted by trypan blue exclusion assay to determine thiopurines in vitro effect on cell growth and survival. Statistical significance was determined by analysis of variance (ANOVA).

RESULTS

Azathioprine and mercaptopurine had a significant time-dependent cytotoxic effect (p-value ANOVA = 0.012), with a viable cell count compared to controls of 55.5% and 67.5% respectively after 48 h and 23.7% and 36.1% after 96 h; no significant difference could be observed between the two drugs. Quantification of thiopurine metabolites evidenced that the most abundant metabolite was TIMP, representing 57.1% and 40.3% of total metabolites after 48 and 96 h. Total thiopurine metabolites absolute concentrations decreased over time: total mean content decreased from 469.9 pmol/million cells to 83.6 pmol/million cells (p-value ANOVA = 0.0070). However, considering the relative amount of thiopurine metabolites, TGMP content significantly increased from 11.4% cells to 26.4% (p-value ANOVA = 0.017). A significant association between thiopurine effects and viable cell counts could be detected only for MeTIMP: lower MeTIMP concentrations were associated with lower cell survival (p-value ANOVA = 0.011). Moreover, the ratio between MeTIMP and TGMP metabolites directly correlated with cell survival (p-value ANOVA = 0.037).

CONCLUSION

Detailed quantification of thiopurine metabolites in a human hepatocytes model provided useful insights on the association between thioguanine and methyl-thioinosine nucleotides with cell viability.

摘要

目的

应用一种创新的液相色谱 - 串联质谱法(LC-MS/MS)对人肝细胞中的硫嘌呤代谢物进行定量,并将其与细胞毒性相关联。

方法

用1.4×10⁻⁶M硫唑嘌呤和1.1×10⁻⁶M巯嘌呤处理永生化人肝细胞(IHH细胞)48小时和96小时,这些浓度对应于先前细胞毒性分析中96小时暴露后计算出的IC值。处理后,收集细胞进行LC-MS/MS分析,以定量11种不同磷酸化水平的硫嘌呤代谢物,并通过台盼蓝排斥试验对活细胞进行计数,以确定硫嘌呤对细胞生长和存活的体外影响。通过方差分析(ANOVA)确定统计学显著性。

结果

硫唑嘌呤和巯嘌呤具有显著的时间依赖性细胞毒性作用(方差分析p值 = 0.012),48小时后与对照组相比活细胞计数分别为55.5%和67.5%,96小时后分别为23.7%和36.1%;两种药物之间未观察到显著差异。硫嘌呤代谢物的定量表明,最丰富的代谢物是TIMP,在48小时和96小时后分别占总代谢物的57.1%和40.3%。硫嘌呤代谢物的总绝对浓度随时间下降:总平均含量从469.9 pmol/百万细胞降至83.6 pmol/百万细胞(方差分析p值 = 0.0070)。然而,考虑硫嘌呤代谢物的相对量,TGMP含量从11.4%显著增加至26.4%(方差分析p值 = 0.017)。仅对于MeTIMP可检测到硫嘌呤效应与活细胞计数之间存在显著关联:较低的MeTIMP浓度与较低的细胞存活率相关(方差分析p值 = 0.011)。此外,MeTIMP与TGMP代谢物之间的比率与细胞存活率直接相关(方差分析p值 = 0.037)。

结论

在人肝细胞模型中对硫嘌呤代谢物进行详细定量,为硫鸟嘌呤和甲基硫代肌苷核苷酸与细胞活力之间的关联提供了有用的见解。

相似文献

1
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay.硫嘌呤类药物在人肝细胞体外模型中的药代动力学和药效学:来自创新质谱分析的见解
Chem Biol Interact. 2017 Sep 25;275:189-195. doi: 10.1016/j.cbi.2017.08.009. Epub 2017 Aug 12.
2
Insights into the cellular pharmacokinetics and pharmacodynamics of thiopurine antimetabolites in a model of human intestinal cells.在人肠细胞模型中硫嘌呤抗代谢物的细胞药代动力学和药效动力学的深入了解。
Chem Biol Interact. 2021 Sep 25;347:109624. doi: 10.1016/j.cbi.2021.109624. Epub 2021 Aug 17.
3
Monitoring of thiopurine metabolites in patients with inflammatory bowel disease-what is actually measured?炎症性肠病患者硫嘌呤代谢物的监测——实际测量的是什么?
Ther Drug Monit. 2009 Jun;31(3):345-50. doi: 10.1097/FTD.0b013e3181a1ea58.
4
Simultaneous quantification of eleven thiopurine nucleotides by liquid chromatography-tandem mass spectrometry.液相色谱-串联质谱法同时测定十一硫嘌呤核苷酸。
Anal Chem. 2012 Feb 7;84(3):1294-301. doi: 10.1021/ac2031699. Epub 2012 Jan 25.
5
Monitoring of thiopurine metabolites - a high-performance liquid chromatography method for clinical use.硫嘌呤代谢物监测 - 一种用于临床的高效液相色谱法。
J Pharm Biomed Anal. 2013 Mar 5;75:145-52. doi: 10.1016/j.jpba.2012.11.027. Epub 2012 Nov 27.
6
Effects of azathioprine, 6-mercaptopurine, and 6-thioguanine on canine primary hepatocytes.硫唑嘌呤、6-巯基嘌呤和6-硫鸟嘌呤对犬原代肝细胞的影响。
Am J Vet Res. 2015 Jul;76(7):649-55. doi: 10.2460/ajvr.76.7.649.
7
Differential toxic effects of azathioprine, 6-mercaptopurine and 6-thioguanine on human hepatocytes.硫唑嘌呤、6-巯基嘌呤和6-硫鸟嘌呤对人肝细胞的不同毒性作用。
Toxicol In Vitro. 2008 Apr;22(3):632-42. doi: 10.1016/j.tiv.2007.12.004. Epub 2008 Jan 25.
8
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.炎症性肠病患者在与氨基水杨酸盐联合治疗期间硫嘌呤代谢产物的变化:N - 乙酰转移酶多态性的影响
World J Gastroenterol. 2015 Mar 28;21(12):3571-8. doi: 10.3748/wjg.v21.i12.3571.
9
Quantification of Thiopurine Metabolites in Human Erythrocytes by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).采用液相色谱-串联质谱法(LC-MS/MS)对人红细胞中的硫嘌呤代谢物进行定量分析。
Methods Mol Biol. 2024;2737:443-452. doi: 10.1007/978-1-0716-3541-4_41.
10
IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations.硫唑嘌呤治疗的炎症性肠病患者的肌苷-5'-单磷酸脱氢酶活性——与硫嘌呤甲基转移酶活性及代谢物浓度的关系
Br J Clin Pharmacol. 2008 Jan;65(1):69-77. doi: 10.1111/j.1365-2125.2007.02985.x. Epub 2007 Jul 27.

引用本文的文献

1
Impact of the loss of slc43a3 on 6-mercaptopurine absorption and tissue distribution in mice.slc43a3缺失对小鼠6-巯基嘌呤吸收及组织分布的影响。
Drug Metab Dispos. 2025 Apr;53(4):100054. doi: 10.1016/j.dmd.2025.100054. Epub 2025 Mar 3.
2
Concomitant 5-aminosalicylic acid treatment does not affect 6-thioguanine nucleotide levels in patients with inflammatory bowel disease on thiopurines.在接受硫嘌呤治疗的炎症性肠病患者中,同时进行5-氨基水杨酸治疗不会影响6-硫鸟嘌呤核苷酸水平。
Ann Gastroenterol. 2023 Nov-Dec;36(6):637-645. doi: 10.20524/aog.2023.0832. Epub 2023 Nov 3.
3
Cytotoxicity of Thiopurine Drugs in Patients with Inflammatory Bowel Disease.
硫嘌呤类药物对炎症性肠病患者的细胞毒性
Toxics. 2022 Mar 22;10(4):151. doi: 10.3390/toxics10040151.
4
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants.炎症性肠病年轻患者中巯嘌呤的生物转化:谷胱甘肽 S-转移酶 M1 和 A1 变体的作用。
Genes (Basel). 2019 Apr 4;10(4):277. doi: 10.3390/genes10040277.